1. Home
  2. NIM vs IXHL Comparison

NIM vs IXHL Comparison

Compare NIM & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Select Maturities Municipal Fund

NIM

Nuveen Select Maturities Municipal Fund

HOLD

Current Price

$9.48

Market Cap

116.1M

Sector

Finance

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.29

Market Cap

134.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NIM
IXHL
Founded
1992
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
116.1M
134.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NIM
IXHL
Price
$9.48
$0.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
35.4K
7.0M
Earning Date
01-01-0001
02-13-2026
Dividend Yield
3.46%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.28
$0.08
52 Week High
$9.74
$2.25

Technical Indicators

Market Signals
Indicator
NIM
IXHL
Relative Strength Index (RSI) 61.85 26.52
Support Level $9.27 $0.30
Resistance Level $9.44 $0.34
Average True Range (ATR) 0.09 0.02
MACD 0.01 -0.01
Stochastic Oscillator 85.65 6.57

Price Performance

Historical Comparison
NIM
IXHL

About NIM Nuveen Select Maturities Municipal Fund

Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: